This Week in Pharmacy

Congratulations to Logan Eury and his new wife Emily, got married today, May 1, 2026! This C.O. Bigelow Collab Introduces the 188-Year-Old Pharmacy to a New Generation Abbode is taking over the Carolyn Bessette-Kennedy-approved shop for a month-long pop-up.https://fashionista.com/2026/05/co-bigelow-abbode-pop-up-carolyn-bessette-impact The article highlights how a pop-up and renewed interest in C.O. Bigelow has been fueled by the cultural resurgence of Carolyn Bessette-Kennedy’s minimalist style, amplified by media and social buzz. This renewed attention has driven significant foot traffic and sales, showing how storytelling, nostalgia, and “quiet luxury” aesthetics can translate into real retail impact. Q&A: Mayo Clinic leaders share strategies for managing high-cost drugs without breaking the bank | Asembia AXS26 Summit https://www.managedhealthcareexecutive.com/view/q-a-mayo-clinic-leaders-share-strategies-for-managing-high-cost-drugs-without-breaking-the-bank-asembia-axs26-summitMayo Clinic leaders emphasize that managing high-cost drugs requires clear definitions, structured formulary review processes, and multidisciplinary collaboration to balance cost, access, and clinical value. They highlight the importance of evaluating safety, efficacy, financial impact, and site-of-care decisions together, while noting that non-340B systems face increasing pressure from rising costs and reimbursement constraints. Ultimately, success depends on stronger alignment between health systems, manufacturers, and payers to sustain access without compromising quality of care. Where Gross-to-net Pressure Actually Lives After LaunchToday’s guest post comes from Cindy Baksh, Chief Product Officer at ConnectiveRx.https://www.drugchannels.net/2026/05/where-gross-to-net-pressure-actually.htmlThe article explains that “gross-to-net pressure” isn’t driven by a single factor, but by a combination of rebates, discounts, fees, and policy changes that continue to reshape how drug pricing actually works behind the scenes. As the industry shifts toward a “net pricing” model, traditional rebate-driven strategies are weakening, forcing manufacturers, PBMs, and pharmacies to rethink how value and profits are generated.Today's featured guest is Dr. Ndidiamaka Okpareke PharmD for CongressDr. Ndidiamaka “Didi” Okpareke, PharmD, is a pharmacist, entrepreneur, and political candidate running for Congress in New Mexico’s 1st Congressional District. A first-generation Nigerian-American, she built her career in healthcare after graduating from the University of New Mexico College of Pharmacy and went on to found and lead a successful compounding pharmacy serving her community. Motivated by nearly two decades of patient care experience, Okpareke entered the political arena to address challenges such as healthcare access, rising costs, and the shortage of providers in New Mexico. Running as a Republican, she emphasizes strengthening healthcare systems, supporting economic growth, and preserving opportunity for future generations, positioning herself as a community-focused leader bringing frontline healthcare insight into public policy. This special episode highlights how TJM Labs is redefining pharmacy operations through AI-driven automation, bringing together insights from industry leaders Bhavesh Patel, PharmD—CEO of Carepoint Pharmacy—and Jonathan Adly, PharmD, MBA—CEO of TJM Labs. At the center of the conversation is how modern pharmacies are facing rising prescription volumes, staffing constraints, and increasing operational complexity, and why traditional manual workflows can no longer keep pace. TJM Labs addresses this challenge by deploying AI-powered “digital workers” that automate tasks like prescription intake, data entry, and patient communication—allowing pharmacy teams to shift their focus back to patient care and clinical decision-making. Through the lens of both operator and innovator, the discussion explores how AI is not replacin

TWIRx News:The FDA plans to remove 12 peptide bulk drug substances from Category 2 of the Section 503A compounding list after their nominations were withdrawn. For compounders, the key issue is that this change does not automatically make compounding these substances permissible, leaving pharmacies exposed to ongoing regulatory uncertainty until the FDA makes further decisions.A nationwide Class II recall has been issued for Xanax XR 3 mg tablets in 60-count bottles, lot 8177156, after the product failed dissolution testing. Pharmacists should immediately locate and quarantine affected stock while reminding patients not to stop benzodiazepine therapy suddenly without direction from a healthcare provider.Community pharmacies are taking on a larger role in wound care by serving as an accessible first point of contact for patients with minor injuries. Pharmacists can help assess wounds, recommend appropriate over-the-counter treatment, watch for warning signs of complications, and refer patients for higher-level care when needed.Special sponsor interview with Allison Arant with Clearway Health. Featured interview with the World's Leading Innovation Theorist John NostaGuests & sponsors of today's TWIRx, Perigon 360 Pharmacy with Chris Antypas PharmD and ed Mills And a bonus interview with Dr. Andy Krut PharmD, on Psychedelics (e.g., LSD, psilocybin, DMT)

TWIRx – April 3, 2026Co-Host: Jesse McCullough On today’s episode of This Week in Pharmacy – TWIRx, we welcome special co-host Jesse McCullough for a timely discussion focused on pharmacy innovation, compliance, advocacy, and the future of the profession. We begin with our featured sponsor segment presented by MatchRx, spotlighting two important voices in pharmacy technology and compliance. Johny Kello, CEO of MatchRx, joins the show alongside Riya Cao, CEO of LSPedia, for an important conversation centered on DSCSA readiness and the evolving world of pharmacy compliance. This discussion explores how pharmacies and supply chain stakeholders can better prepare for regulatory expectations, protect patients, and strengthen operational transparency through smarter compliance solutions. In the second half of the episode, we’re joined by Scott Brunner, CEO of the Alliance for Pharmacy Compounding (APC), for a recap of the Owner Summit 2026 and a look ahead at what’s developing on Capitol Hill. Scott shares insight into the policy landscape impacting pharmacy compounding, the priorities emerging from this year’s summit, and what pharmacy owners and industry leaders should be watching as legislative and regulatory conversations continue to evolve. This episode of TWIRx delivers a strong pulse on the profession—from compliance and interoperability to advocacy and the future of compounding pharmacy. Featured Guests: Johny Kello, CEO, MatchRx Riya Cao, CEO, LSPedia Scott Brunner, CEO, Alliance for Pharmacy Compounding (APC) Episode Topics: DSCSA and pharmacy compliance Supply chain visibility and readiness MatchRx and LSPedia collaboration in pharmacy compliance Owner Summit 2026 recap Capitol Hill updates impacting pharmacy compounding The future of compounding and pharmacy advocacy Sponsored by:MatchRx DSCSA Compliance and Compounding Leadership | TWIRx

On this week’s This Week in Pharmacy (TWIRx), we explore how innovation, technology, and emerging therapies are reshaping pharmacy practice. From the growing influence of AI in medical information research, to the next generation of pharmacy management systems, and the expanding role of cell and gene therapies, this episode brings together industry leaders to discuss what’s next for pharmacy. Special thanks to this week’s sponsors Cardinal Health, Independent Pharmacy Cooperative (IPC), and Nested Knowledge for supporting the podcast. Segment 1 – AI & the Future of Medical Information with Nested Knowledge Nested Knowledge returns to TWIRx as we welcome back Keith Kallmes, Co-Founder of Nested Knowledge, for an update on how artificial intelligence is transforming the way healthcare professionals access and interpret medical information. Keith explains how AI-powered tools are improving evidence synthesis, systematic literature reviews, and clinical decision support, helping researchers and clinicians navigate the growing volume of medical literature while enabling faster, more reliable insights. Segment 2 – The Evolution of Pharmacy Management Systems with Outcomes Next, we’re joined by Lou Ann Myers from Outcomes to discuss how pharmacy management systems are evolving beyond traditional dispensing. Modern pharmacies require integrated technology connecting billing, treatment planning, clinical tracking, inventory management, and revenue-generating services. Lou Ann shares why these systems must support both clinical services and business sustainability as pharmacies expand into value-based care and new service models. Segment 3 – Emerging Therapies with Cardinal Health In our final segment, we welcome Dr. Fran Gregory, PharmD, Vice President of Emerging Therapies (Cell & Gene, Biosimilars) at Cardinal Health, to discuss one of the most transformative areas in healthcare. Dr. Gregory explores the growing impact of cell and gene therapies and biosimilars, and what these innovations mean for pharmacists, health systems, and specialty pharmacy providers as the industry prepares for new challenges in distribution, access, and reimbursement. About TWIRx (This Week in Pharmacy)TWIRx is the flagship news and commentary podcast from the Pharmacy Podcast Network, delivering weekly insights on the business, technology, and policy shaping the pharmacy profession.

On this episode of This Week in Pharmacy, we spotlight two major conversations shaping the future of pharmacy practice in 2026. First, we welcome Dr. Lisa Faast, PharmD, founder of DiversifyRx, to discuss the Pharmacy Profit Summit 2026 and how independent pharmacies can strengthen margins, diversify revenue streams, and build sustainable growth models in today’s reimbursement environment. Then, we turn to Rare Disease Day 2026 with Richard Faris PharmD, Chief Commercial & Clinical Officer at and PANTHERx Rare, to discuss specialty pharmacy leadership, pharmacist impact, and new patient feedback data revealing communication gaps in rare disease care. Segment 1: Pharmacy Profit Summit 2026Guest: Dr. Lisa Faast, PharmD | Founder, DiversifyRx Dr. Faast joins us to break down the vision behind Pharmacy Profit Summit 2026 — an event designed to equip pharmacy owners with practical strategies to increase profitability while maintaining clinical excellence. Key Topics Covered: • Why independent pharmacies must move beyond traditional dispensing revenue • Diversification strategies including niche services and high-value offerings • Real-world financial benchmarks pharmacy owners should track • How mindset, leadership, and data discipline drive sustainable profitability • The importance of collaboration and shared intelligence among pharmacy entrepreneurs The Pharmacy Profit Summit is not just about revenue — it’s about equipping pharmacy owners to compete intelligently in a rapidly consolidating healthcare market. Segment 2: Rare Disease Day 2026Guest: Richard Faris, PharmD | PANTHERx Rare In recognition of Rare Disease Day 2026, we are honored to welcome Richard Ferris, PharmD, to discuss the critical role pharmacists play in specialty pharmacy and rare disease care. PantherRx recently released survey findings examining patient and caregiver experiences within rare disease treatment journeys. Key Study Highlights: • 90% of patients and caregivers report delays due to communication gaps • 68% report waiting for updates from providers, pharmacies, or insurers • 90% say they manage the care process themselves • 72% desire a dedicated care coordinator • 73% agree it is unclear who is responsible for coordinating rare disease care Despite advances in specialty therapeutics, patients are still asking for the fundamentals: clear communication, coordinated care, and personalized support. Richard discusses: • The growing importance of specialty pharmacists as care coordinators • Why rare disease patients often feel burdened by system fragmentation • How specialty pharmacy can close communication gaps • The need for pharmacist-led continuity in complex therapy management Rare Disease Day reminds us that specialty pharmacy is not only about high-cost medications — it is about human connection, long-term coordination, and advocacy for patients navigating some of the most complex clinical journeys in healthcare. From business sustainability to patient-centered specialty care, this episode reinforces two realities: Pharmacy must remain financially strong to survive.Pharmacists must remain clinically present to lead. As the profession evolves, profitability and patient advocacy are not opposing forces — they are interdependent pillars of pharmacy’s future. Listen now and join the conversation shaping Pharmacy in 2026.

TWIRx – This Week in Pharmacy Episode Date: February 13, 2026Valentine’s Day Special 💘 This week on TWIRx, hosts Stephen Beckman, PharmD and Todd Eury break down the biggest headlines shaping pharmacy, from workforce trends to policy updates and innovation. 💕 Valentine’s Feature: TogetheRx – A Pharmacy Love Story In celebration of Valentine’s Day, we welcome Drs. Mark and Gretchen Garofoli, PharmD, a pharmacy power couple who met at the University of Pittsburgh School of Pharmacy and have built a life and career TogetheRx. Their journey includes raising a family, leading in pharmacy advocacy, podcasting, academic work with WVU School of Pharmacy, and operating a community pharmacy near Morgantown, WV. 🧪 Love Potion Segment: A Historical Rx Dr. Mark Fulton, PharmD, host of the RxTales Podcast, joins the show to explore the surprising history of “love potions” and how folklore intersects with early pharmacy and medicine. 🚀 Innovation Spotlight: RxTransfer & Interoperability We close with Pharmacy 50 Award Winner Alumni 2025, Dr. Lawrence King, PharmD, VP of Product Innovation at Surescripts, discussing RxTransfer, prescription interoperability, and how technology is modernizing pharmacy workflow and patient safety. ❤️ From love stories to pharmacy innovation, this Valentine’s edition celebrates the profession from the heart. Subscribe, listen, and share as we head into Valentine’s Day 2026.

TWIRx – January 30 | Special Guest: Marc Essensa, CEO of IPC On this episode of This Week in Pharmacy, we welcome Marc Essensa, President and CEO of the Independent Pharmacy Cooperative (IPC), to discuss timely strategies and resources helping independent pharmacies strengthen their businesses in today’s challenging environment. Building Your Independent Pharmacy Business Marc shares insights on navigating reimbursement pressure, improving margins, and leveraging IPC’s purchasing power, data, and strategic tools to support long-term sustainability. The Payment Card Settlement: A Practical Guide We break down IPC’s guidance on the Payment Card Interchange Fee Settlement, which may allow pharmacies that accepted Visa or Mastercard between 2004–2019 to recover funds. Marc explains eligibility, next steps, and how recovered dollars can support cash flow, staffing, technology, or inventory investments. IPC Member Support Services The conversation highlights IPC’s expanded member support offerings, including business consulting, strategic partnerships, wholesale access, and operational resources designed to help independents stay competitive. Legislative & Advocacy Updates Marc also provides updates on IPC’s advocacy efforts at both the state and federal levels, focused on protecting independent pharmacy interests and addressing ongoing policy and reimbursement challenges. 🔗 Resource Mentioned The Payment Card Settlement: A Practical Guide – IPChttps://www.ipcrx.com/pharmacy-blog/news/the-payment-card-settlement-a-practical-guide/ Special guest: Sakhi Gaurang Patel is a trailblazing PharmD candidate at the UC Irvine School of Pharmacy & Pharmaceutical Sciences and a co-founder of the startup CuraVoice. Recognized for her work in healthcare equity, mentorship, and educational technology, she focuses on improving patient communication and reducing health disparities. Featured Guest: Dr. Jenny Newlon, PharmD — Researcher and Pharmacist with Birth Control Pharmacist In this episode of This Week in Pharmacy, we sit down with Dr. Jenny Newlon to explore how pharmacist consultants, health clinics, and independent pharmacies can build high-value contraception services that meet urgent community needs.We discuss practical strategies for delivering accessible birth control care—especially in areas that have lost Planned Parenthood centers—while creating new revenue models outside the constraints of traditional PBM reimbursement. Dr. Newlon breaks down: How pharmacies can implement contraception services—even with limited staff or clinical infrastructure Ways to deliver value to patients and communities through education, access, and continuity of care Forward-thinking business models that diversify revenue beyond dispensing Tune in to learn how independent pharmacy teams can lead with care, expand women’s health access, and strengthen their role as trusted healthcare providers.Today's "This Week in Pharmacy" is sponsored by Independent Pharmacy Cooperative (IPC)

🎙️ This Week in Pharmacy (TWIRx) — January 9, 2026 Welcome to TWIRx — This Week in Pharmacy! I’m your host Todd Eury, and today’s episode is sponsored by YARAL Pharma, a generics company committed to “Doing Things Differently”—with a human-centered, untraditional approach that’s redefining relationships between industry and pharmacy practice. ✅ Today’s Sponsor: YARAL Pharma YARAL Pharma is committed to innovation, partnership, and supporting pharmacists at the front lines—especially as healthcare continues to restructure and the role of the pharmacist becomes more essential than ever. Their mission to Do Things Differently is more than a slogan—it’s a commitment to reshaping what a generics company can stand for in today’s healthcare marketplace. 📰 This Week in Pharmacy — News 1) Amazon Pharmacy to Offer Novo Nordisk’s Wegovy Pill Nationwide Amazon Pharmacy is now offering Novo Nordisk’s newly FDA-approved Wegovy pill, making the weight-loss medication available nationwide through both insurance coverage and cash-pay options. This move continues Amazon’s expansion into digital healthcare access—bringing blockbuster GLP-1 therapies directly to consumers and increasing competition among major pharmacy providers.https://www.mobihealthnews.com/news/amazon-pharmacy-offer-novo-nordisks-wegovy-pill 2) Dr. David Pope: AI, Online Pharmacies, and Why the Neighborhood Pharmacist Still Wins Trust In a must-read guest column, Dr. David Pope argues that while AI and online pharmacy services are rapidly surging, the community pharmacist remains one of the most trusted healthcare professionals in America. He points to how pharmacy deserts, increasing reimbursement pressure, and policy reform will reshape pharmacy in 2026—and why the profession’s future will depend on protecting and empowering local pharmacy care.https://drugstorenews.com/ai-and-online-pharmacy-surge-neighborhood-pharmacist-remains-most-trusted 3) Pharmacist Leadership Spotlight: Illuminate Rx Names Ritu Malhotra, PharmD, as President Illuminate Rx announced the appointment of Ritu Malhotra, PharmD, as its new President, reinforcing the growing trend of pharmacists stepping into leadership roles across pharmacy benefits and PBM reform. With decades of experience modernizing healthcare and pharmacy benefit strategy, Malhotra’s appointment signals Illuminate Rx’s focus on improving transparency and clarity in pharmacy benefits management.https://www.prnewswire.com/news-releases/illuminate-rx-appoints-industry-veteran-ritu-malhotra-pharmd-as-president-to-advance-clarity-in-pharmacy-benefits-302657441.html 4) Viatris Exec David Marin Named New CEO of PCMA The Pharmaceutical Care Management Association (PCMA)—the leading PBM trade group—has named David Marin, previously Head of Global Government Affairs & Public Policy at Viatris, as its next President and CEO effective January 30, 2026. His selection comes at a pivotal time as PBMs face rising scrutiny and intensifying policy pressure nationwide.https://www.healthcaredive.com/news/pcma-names-new-ceo-david-marin/809158/ 🎤 Interviews & Segments ⭐ Segment 1 — Special Sponsor Interview Stephen Beckman, CEO of YARAL Pharma We kick off TWIRx with a special conversation featuring Stephen Beckman, CEO of YARAL Pharma, exploring what 2026 has in store for pharmacy and healthcare. We discuss the Pharmacy 50 Awards, the importance of honoring leadership across the profession, and why supporting pharmacists right now—during one of the most fragile and transformative moments in U.S. healthcare—is absolutely critical. ⭐ Featured Interview — Pennsylvania State Representative Rep. Charity Grimm Krupa — 51st Legislative District Today’s featured interview is with State Representative Charity Grimm Krupa, who represents Pennsylvania’s 51st Legislative District in the House of Representatives. We discuss real healthcare issues impacting Pennsylvanians—including medical cannabis, small business healthcare benefit strategies, a

Up first, Inspirogene-by-McKesson with Joe DePinto InspiroGene" is a dedicated business unit launched by McKesson in October 2024, focused solely on supporting the commercialization of cell and gene therapies (CGTs). It leverages McKesson's expertise in supply chain, logistics, and specialty pharmacy to help manufacturers, payers, and providers navigate the complex CGT landscape.https://www.mckesson.com/business-solutions/our-businesses/inspirogene-by-mckesson/Our featured interview:Sponsored by MatchRXThe TrumpRx Playbook for Independent Pharmacies CEO of MatchRx Johny Kello co-hosts with Todd Eury featuring our guest speaker, Dae Lee, Pharm.D., Esq., CPBS. Dae is a pharmacist-attorney and a Shareholder in the FDA & Biotechnology practice at Buchanan Ingersoll & Rooney. What makes Dae especially valuable for this conversation is that he’s not just reading policy from 30,000 feet — he represents pharmacies every day in high-stakes fights with PBMs, from audits and reimbursement disputes to network suspensions and terminations.So, when we talk about TrumpRx — how it works, what it could break, and what independents should do next — Dae can translate the legal and contracting reality into real-world consequences behind the counter.Connect with MatchRX: MatchRX.comSpecial Message from Greg Reybold with APCI, update of the "Pharmacists Fight Back Act"Connect with Greg: https://www.apcinet.com/Next, we talk with Dr. Jessica Daley PharmD Fractional Supply Chain and Operations Executive, with Pharma Logistics, we dicuss drug shortages and strategies for 2026.Connect with Jessica: https://www.linkedin.com/in/jessicaldaley/Last interview, a suprise message from International Pharmacy 50 Pharmacist & Author Katrina Azer, announcing her new book https://www.katrinaazer.com/#books

This Week in Pharmacy – Friday, December 5th Strengthening the Pharmacy Workforce: A Conversation with Crystal Lennartz Cutting Through the AI Confusion: Shaun Jensen on Smarter Pharmacy OperationsThe New 340B Reality: Allison Arant on Navigating HRSA’s Rebate Model Welcome to another episode of This Week in Pharmacy, where we bring together the most important conversations, industry insights, and breaking pharmacy news shaping the future of healthcare. Today’s show features a powerhouse lineup of leaders driving innovation across retail pharmacy, technology, consulting, and 340B health-system strategy. 🟦 Segment 1 — Interview with Crystal Lennartz, President of Health Mart & Health Mart Atlas We open the show with a conversation with Crystal Lennartz, President of Health Mart and Health Mart Atlas, about the evolving role of workforce management in independent pharmacies. 📰 TWIRx News — Friday, December 5th A fast roundup of the top stories impacting pharmacy this week: 👉 Humana Exploring Partnership with Mark Cuban Humana is reportedly in discussions with Mark Cuban to explore a potential pharmacy partnership that could disrupt traditional PBM and drug-supply models. The collaboration may reshape how medications are priced and accessed—another sign that alternative pharmacy models are gaining traction. 👉 New Migraine Therapy: Symbravo Pharmacists should be aware of Symbravo, a new dual-action migraine therapy combining meloxicam and rizatriptan. Importantly, the product is non-substitutable, meaning pharmacies must dispense exactly as written. The therapy adds a new tool for acute migraine care but requires careful patient counseling on cardiovascular risks, medication-overuse headaches, and NSAID interactions. 👉 Walgreens Expands Automated Fulfillment Centers Walgreens continues restructuring by expanding its automated micro-fulfillment pharmacy network. Robots are now filling a growing percentage of maintenance prescriptions, allowing pharmacists to refocus on clinical services. The move signals accelerating automation across retail pharmacy as chains seek cost savings and operational efficiency. 🟦 Segment 2 — Interview with Shaun Jensen, CEO of JB Consulting Group Next, we speak with Shaun Jensen, CEO of JB Consulting Group, about the rising confusion many pharmacy operators face around AI adoption.We discuss: Where AI adds true efficiency versus where it’s misunderstood Practical steps for pharmacy owners to implement AI tools How data-driven automation can improve workflow, inventory, prior authorizations, and patient communication The mindset shift required for pharmacies to thrive in an AI-supported future 🟦 Segment 3 — Interview with Allison Arant, SVP of Client Development & Marketing, Clearway Health Our final interview is with Allison Arant from Clearway Health, focusing on the new challenges hospital systems face as HRSA launches the 340B rebate model.Key discussion points: How the rebate model changes operational and financial dynamics for 340B hospitals Why safety-net hospitals caring for large uninsured and underinsured populations are feeling heightened pressure Strategies Clearway Health is deploying to help health systems navigate rising medication costs, compliance demands, and shrinking margins What health-system pharmacies must prepare for heading into 2026 This week’s conversations underscored a unifying theme: the pharmacy industry is entering a period of rapid transformation, driven by new reimbursement models, automation, innovation partnerships, and evolving expectations from both patients and payers. Independent pharmacies, health systems, and specialty operators all face challenges—but also significant opportunities for reinvention, collaboration, and leadership. Thank you for tuning in to This Week in Pharmacy. Stay informed, stay inspired, and keep pushing our profession forward. Walgreens doubles down on automation to reshape pharmacy operations. The retail pharmacy

On "This Week in Pharmacy" #TWIRx TWIRx NEWS This Week in Pharmacy News – A trio of developments highlight major shifts and ongoing challenges in pharmacy care:Fruth Pharmacy, a 73-year-old family-owned regional pharmacy chain in West Virginia and Ohio, has been acquired by Walgreens Boots Alliance, with transfer of prescription files and inventory from 16 stores planned for December 3 — the deal underscores how legacy community pharmacies are increasingly consolidating to survive pressure from reimbursement and PBM models.- from Mass Market Retailershttps://lnkd.in/emKagG9v At UNC Eshelman School of Pharmacy, the Postgraduate Year One Community-based Pharmacy Residency Program is celebrating 25 years, having trained 163 residents who serve in community pharmacies across North Carolina. With 95 % of Americans living within five miles of a pharmacy, the program emphasizes the critical role of community pharmacists in rural and underserved areas.https://lnkd.in/e-Gk5bkr A new commentary from Those Nerdy Girls draws attention to the growing crisis of “pharmacy deserts” — areas lacking accessible pharmacies — and links closures of independent and chain pharmacies (nearly 1 in 3 since 2010) with inequities in care for rural, Black and Latino-majority neighborhoods. The piece calls for PBM reform, policy action and community engagement to preserve pharmacy access.https://lnkd.in/ezxmdRfb Featured Sponsor today: MatchRX presents: Understanding #DSCSA and the Road to 2026 Special Guest: Ilisa Bernstein PharmD, JDCEO & Co-founder Johny Kello with MatchRXJohny welcomes one of the "50 Most Influential People in Pharmacy", Ilisa B.G. Bernstein, PharmD, JD, to break down the current state of DSCSA compliance as the industry approaches the critical November 2025 enforcement deadline. With decades of leadership in pharmacy practice, regulatory policy, and national advocacy, Dr. Bernstein brings unmatched clarity to what pharmacies must do now — and how the right technology partnerships can keep them operational, efficient, and fully compliant.Learn more: https://www.matchrx.com/Featured Guest:Dr. Dr. Jordyn Nordé, PharmD, MBA is a forward-thinking clinical hashtag#pharmacist and community leader based in St. Louis who combines advanced clinical training with business acumen to drive impact in underserved populations. With experience in ambulatory care and medication management for conditions like hypertension, diabetes and pain, she is also the founder of an initiative bringing minority pharmacy professionals together through mentorship, entrepreneurship and wellness conversations. Her dual credentials enable her to bridge healthcare, professional development and advocacy — positioning her as an emerging influencer in pharmacy practice transformation. Du2SXEoupKHwm2ROh5lf

This Week in Pharmacy - November 7, 2025 TWIRx News: First up, Binghamton University School of Pharmacy holds emergency management simulation, VCU Health pharmacies expand access through new home delivery options, and Lilly and U.S. government agree to expand access to obesity medicines to millions of Americans. Our special guest line up on TWIRx: Amantha Bagdon - CEO of RxPost PGX Pharmacist's Protection of Patients with Dr. Melissa Smith PharmD Arkansas HB 1150 TO PROHIBIT A PHARMACY BENEFITS MANAGER FROM OBTAINING CERTAIN PHARMACY PERMITS. with John Vinson CEO of the Arkansas Pharmacy Association & Greg Reybold with APCI 4th Generation Pharmacy Owner C.O. Bigelow (the oldest Apothecary in America) the Drugstore Cowboy, Alec Gingsberg PharmD Thank you to our sponsors: Independent Pharmacy Cooperative (IPC) Yaral Pharma SureCost The Drugstore Cowboy Rides Again: PBM Reform in Arkansas & PGx Safeguards for Xeloda Patients | TWIRx

Access, Advocacy & Appreciation: The Heart of Pharmacy in Motion --it's time to #TWIRx on October 24th, 2025, it's FRIDAY!! Up first is TWIRx News:From Pharmacy Times, Lynkuet Access Program Aims to Help Women Save on Neurokinin-Targeted Therapy. https://lnkd.in/e2CwGUt8NEXT from Drug Store News, Pharmacies can close health care gaps for millions while realizing substantial savings for employers A new national study from the Health Action Alliance, commissioned by NACDS, shows pharmacy-based care reduces costs while meeting employee demands for convenient access. https://lnkd.in/eYmrQnHQNEXT from Open PR, New Research Peptide Supplier Plans Pharmacy Collaborations to Support Licensed Wellness Clinic Sector https://lnkd.in/evkgZtn5NEXT Study shows alarming drop in pharmacy access in Massachusetts --reporting from WWLP-22News from Boston https://lnkd.in/egWg6G3rIn this episode of This Week in Pharmacy, host Todd Eury welcomes featured guest Tiara Green, President of Accessia Health, whose mission is to connect patients without insurance to life-saving medication funding.LINK: https://lnkd.in/gV4VjeZn We also check in with Jesse McCullough for Day 24 of the 31-Day #Pharmacist Month Challenge, with a special call to action to support the 40+ shows and incredible hosts creating content for the pharmacy profession through the Pharmacy Podcast Network.LINK: https://lnkd.in/efvZ6Smv Plus, Mike Johnston, CPhT-Adv, CEO of the NPTA - National Pharmacy Technician Association (NPTA), joins us to share insights on Meaningful Recognition and what pharmacy technicians truly want as we celebrate World Pharmacy Technician Day.LINK: https://lnkd.in/gz-Gcxvg 🎧 Empowering the profession, one story at a time.Thank you to Independent Pharmacy Cooperative (IPC) and Sykes & Company, P.A. for always supporting #TWIRx in the Works!!